Literature DB >> 26318600

Hydrogen sulfide and PKG in ischemia-reperfusion injury: sources, signaling, accelerators and brakes.

Ioanna Andreadou1, Efstathios K Iliodromitis, Csaba Szabo, Andreas Papapetropoulos.   

Abstract

Over the past decade, hydrogen sulfide has emerged as an important cardioprotective molecule with potential for clinical applications. Although several pathways have been proposed to mediate the beneficial effects of H2S, the NO/cGMP axis has attracted significant attention. Recent evidence has suggested that cGMP-dependent protein kinase can lie both downstream and upstream of H2S. The current literature on this topic is reviewed and data from recent studies are integrated to propose a unifying model.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26318600      PMCID: PMC4667708          DOI: 10.1007/s00395-015-0510-9

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  50 in total

1.  The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat.

Authors:  A Sivarajah; M C McDonald; C Thiemermann
Journal:  Shock       Date:  2006-08       Impact factor: 3.454

2.  Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes.

Authors:  Jin-Song Bian; Qian Chen Yong; Ting-Ting Pan; Zhan-Ning Feng; Muhammed Yusuf Ali; Shufeng Zhou; Philip Keith Moore
Journal:  J Pharmacol Exp Ther       Date:  2005-10-04       Impact factor: 4.030

3.  The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide.

Authors:  R Hosoki; N Matsuki; H Kimura
Journal:  Biochem Biophys Res Commun       Date:  1997-08-28       Impact factor: 3.575

4.  Intravenous administration of the natriuretic peptide urodilatin at low doses during coronary reperfusion limits infarct size in anesthetized pigs.

Authors:  F Padilla; D Garcia-Dorado; L Agulló; J A Barrabés; J Inserte; N Escalona; M Meyer; M Mirabet; P Pina; J Soler-Soler
Journal:  Cardiovasc Res       Date:  2001-08-15       Impact factor: 10.787

5.  Effect of sildenafil on reperfusion function, infarct size, and cyclic nucleotide levels in the isolated rat heart model.

Authors:  Eugene Francois du Toit; Ellen Rossouw; Ruduwaan Salie; Lionel Henry Opie; Amanda Lochner
Journal:  Cardiovasc Drugs Ther       Date:  2005-01       Impact factor: 3.727

6.  Atrial natriuretic peptide administered just prior to reperfusion limits infarction in rabbit hearts.

Authors:  Xi-Ming Yang; Sebastian Philipp; James M Downey; Michael V Cohen
Journal:  Basic Res Cardiol       Date:  2006-04-08       Impact factor: 17.165

7.  Urodilatin limits acute reperfusion injury in the isolated rat heart.

Authors:  J Inserte; D Garcia-Dorado; L Agulló; A Paniagua; J Soler-Soler
Journal:  Cardiovasc Res       Date:  2000-01-14       Impact factor: 10.787

8.  H2S generated by heart in rat and its effects on cardiac function.

Authors:  Bin Geng; Jinghui Yang; Yongfen Qi; Jing Zhao; Yongzheng Pang; Junbao Du; Chaoshu Tang
Journal:  Biochem Biophys Res Commun       Date:  2004-01-09       Impact factor: 3.575

9.  Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function.

Authors:  John W Elrod; John W Calvert; Joanna Morrison; Jeannette E Doeller; David W Kraus; Ling Tao; Xiangying Jiao; Rosario Scalia; Levente Kiss; Csaba Szabo; Hideo Kimura; Chi-Wing Chow; David J Lefer
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-18       Impact factor: 11.205

10.  The possible role of hydrogen sulfide as an endogenous neuromodulator.

Authors:  K Abe; H Kimura
Journal:  J Neurosci       Date:  1996-02-01       Impact factor: 6.167

View more
  5 in total

Review 1.  Hydrogen sulfide, an enhancer of vascular nitric oxide signaling: mechanisms and implications.

Authors:  Csaba Szabo
Journal:  Am J Physiol Cell Physiol       Date:  2016-10-26       Impact factor: 4.249

Review 2.  International Union of Basic and Clinical Pharmacology. CII: Pharmacological Modulation of H2S Levels: H2S Donors and H2S Biosynthesis Inhibitors.

Authors:  Csaba Szabo; Andreas Papapetropoulos
Journal:  Pharmacol Rev       Date:  2017-10       Impact factor: 25.468

3.  Low-Cytotoxicity Fluorescent Probes Based on Anthracene Derivatives for Hydrogen Sulfide Detection.

Authors:  Xuefang Shang; Jie Li; Yaqian Feng; Hongli Chen; Wei Guo; Jinlian Zhang; Tianyun Wang; Xiufang Xu
Journal:  Front Chem       Date:  2018-06-05       Impact factor: 5.221

Review 4.  Trends in H2S-Donors Chemistry and Their Effects in Cardiovascular Diseases.

Authors:  Angela Corvino; Francesco Frecentese; Elisa Magli; Elisa Perissutti; Vincenzo Santagada; Antonia Scognamiglio; Giuseppe Caliendo; Ferdinando Fiorino; Beatrice Severino
Journal:  Antioxidants (Basel)       Date:  2021-03-11

Review 5.  Evidence for the Benefits of Melatonin in Cardiovascular Disease.

Authors:  Mohammad Tobeiha; Ameneh Jafari; Sara Fadaei; Seyed Mohammad Ali Mirazimi; Fatemeh Dashti; Atefeh Amiri; Haroon Khan; Zatollah Asemi; Russel J Reiter; Michael R Hamblin; Hamed Mirzaei
Journal:  Front Cardiovasc Med       Date:  2022-06-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.